France· FR:62915880
BLEU PATENTE V SODIQUE GUERBET 2,5 POUR CENT, solution injectable
A medicinal product containing bleu patenté v sodique, registered in France by GUERBET.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BLEU PATENTÉ V SODIQUE
- Manufacturer
- GUERBET
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009312380345 ampoule(s) en verre de 2 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bleu patenté v sodique in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyPatentblau V AzultisProvepharm Sas
- United KingdomPatent blue V 2.5% solution for injection 2ml ampoulesImported (France)
- BelgiumBleu Patente V Guerbet 2.5 g/100 mlGuerbet
- SpainAZUL PATENTE AZULTIS 25 MG/ML SOLUCION INYECTABLE EFGProvepharm
- NorwayBleu Patente V guerbetGuerbet
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Patentblau V Azultis
- Belgium · Bleu Patenté V Guerbet
- Germany · Patentblau V Azultis, Patentblau V Guerbet
- Spain · Azul Patente Azultis
- Hungary · Patent Blue V Sodium Azultis Provepharm, Patentblue Guerbet
- Luxembourg · Bleu Patenté V Guerbet
- Netherlands · Bleu Patente V Guerbet, Patentblauw V Azultis
- Slovakia · Patentblau V Guerbet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/36f629e5-ed12-47df-843e-15dce2353b05 GET /v1/drugs/36f629e5-ed12-47df-843e-15dce2353b05?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62915880",
"date_amm": "1997-12-10",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BLEU PATENTÉ V SODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraartérielle;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bleu patenté v sodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.